Will NCT06987695 (Amgen) still show a study completion date of 21 July 2027 or earlier when checked on 20 August 2027?
deadline 2027-08-20
confidence medium
tier 4 evidence
58%PolySignal estimate
Resolution criterion
Yes if, when NCT06987695 is read on clinicaltrials.gov on 20 August 2027, the exact API field protocolSection.statusModule.completionDateStruct.date — Study Completion Date is 21 July 2027 or earlier — that is, the date announced today has not been pushed back. A later recorded date counts as no. If OverallStatus is Terminated, Withdrawn, Suspended, or Unknown status, that counts as no — an unmaintained or halted record is treated as a failure to hold the date, not as a technicality. The value returned by the ClinicalTrials.gov API on the deadline prevails; where the record gives a month without a day, the last day of that month is used. If that exact field is absent or empty on an otherwise existing record, that also counts as no – a missing date is not evidence the deadline will be met, it is treated the same as a halted record.
Verified starting state
As of 6 October 2026: NCT06987695 is registered as ACTIVE_NOT_RECRUITING, sponsored by Amgen, with 279 participants. Started 2025-06; announced primary completion 2027-04-27, announced study completion 2027-07-21. Record last updated 2025-12-17. The date under test is 2027-07-21. Source: clinicaltrials.gov/study/NCT06987695
What pushes it up
- The trial is already in 'ACTIVE_NOT_RECRUITING' status, eliminating recruitment delays, which are the leading cause of trial slippage [1].
- Amgen is an experienced, well-resourced sponsor capable of keeping trials on schedule [1].
What pushes it down
- Any delay beyond the July 21, 2027 date, even by a few days, results in a 'No' resolution.
- The registry has not been updated since December 2025, meaning potential schedule adjustments may not have been logged yet [1].
What would move this number most
Whether the remaining follow-up and data collection phases encounter any operational or administrative delays.
How this number is built
| Deadline | 2027-08-20 |
| Base rate | 65% |
| Best evidence | tier 4 · 0 article(s) used |
| Independent runs | 55 · 60 (spread 5 pts) |
| Confidence | medium |
| Evidence cap | not triggered |
| Last revised | 2026-10-06 07:36 |
| Model | gemini-3.5-flash |